Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: Effect of the tissue factor pathway inhibitor

Blood

Volumn 84, Issue 4, 1994, Pages 1132-1142

  Van 't Veer, Cornelis ^a   Hackeng, Tilman M ^a   Delahaye, Cecile ^a   Sixma, Jan J ^a   Bouma, Bonno N ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; FRESH FROZEN PLASMA; THROMBIN; THROMBOPLASTIN;

ARTICLE; BLEEDING TENDENCY; BLOOD CLOTTING TEST; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEMOPHILIA A; HEMOPHILIA B; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UMBILICAL VEIN;

EID: 0027932735     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v84.4.1132.1132     Document Type: Article

References (47)

1. Radcliffe R, Nemerson Y: Activation and control of FVII by activated factor X and thrombin. J Biol Chem 250:388, 1975
2. Nemerson Y, Repke D: Tissue factor accelerates the activation of coagulation factor VII: The role of a bifunctional coagulation cofactor. Thromb Res 40:351, 1985
3. Rao LVM, Rapaport SI: Activation of FVII bound to tissue factor: A key early step in the tissue factor pathway of blood coagulation. Proc Natl Acad Sci USA 85:6687, 1988
4. Osterud B, Rapaport SI: Activation of factor IX by the reaction product of tissue-factor and factor VII: Additional pathway for initiating coagulation. Proc Natl Acad Sci USA 74:5260, 1977
5. Lawson JH, Butanas S, Mann KG: The evaluation of complex-dependent alterations in human factor VIIa. J Biol Chem 267:4834, 1992
6. 2+, phospholipids, and tissue-factor apoprotein to the activation of human blood coagulation factor X by activated factor VII. Biochem J 265:327, 1990
7. Jackson CM, Suttie JW: Prothrombin structure, activation and biosynthesis. Physiol Rev 57:1, 1977
8. Rapaport SI: The extrinsic pathway inhibitor: A regulator of tissue factor-dependent blood coagulation. Thromb Haemost 66:6, 1991
9. Girard TJ, Warren LA, Novotny WF. Likert KM, Brown SG, Miletich JP, Broze GJ Jr: Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature 338:518, 1989
10. Gemmel CH, Broze GJ, Turitto VT, Nemerson Y: Utilization of a continuous flow reactor to study the lipoprotein associated coagulation inhibitor that inhibits tissue factor. Blood 76:2266, 1990
11. Sandset PM, Warn-Cramer BJ, Rao LVM, Maki SL, Rapaport SI: Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue-factor: Evidence supporting a physiologic role for EPI as a natural anticoagulant. Proc Natl Acad Sci USA 88:708, 1991
12. Warner-Cramer BJ, Rapaport SI: Studies of factor Xa/phospholipid-induced coagulation in rabbits: Effects of immunodepletion of tissue factor pathway inhibitor. Arterioscler Thromb 13:1551, 1993
13. Gramzinski RA, Broze GJ Jr, Carson SD: Human fibroblast tissue factor is inhibited by lipoprotein-associated coagulation inhibitor and placental anticoagulant protein but not by apolipoprotein A-II. Blood 73:983, 1989
14. Almus FE, Rao LVM, Rapaport SI: Functional properties of FVIIa/TF formed with purified tissue factor and tissue factor expressed on cultured endothelial cells. Thromb Haemost 62:1067, 1989
15. Gemmell CH, Turitto VT, Nemerson Y: Flow as a regulator of the activation of factor X by tissue factor. Blood 72:1404, 1988
16. Nemerson Y, Turitto VT: The effect of flow on hemostasis and thrombosis. Thromb Haemost 66:272, 1991
17. Repke D, Gemmel CH, Guha A, Turrito VT, Broze GJ Jr, Nemerson Y: Hemophilia as a defect of the tissue-factor pathway of blood coagulation: Effect of factors VIII and IX on factor X activation in a continuous-flow reactor. Proc Natl Acad Sci USA 87:7623, 1990
18. Schoen P, Lindhout T, Willems G: Continuous flow and the prothrombinase-catalyzed activation of prothrombin. Thromb Haemost 64:542, 1990
19. Ryan J, Brett J, Tijburg PNM, Bach RR. Kisiel W, Stern DM: Tumor necrosis factor-induced endothelial tissue-factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface. Blood 80:966, 1992
20. Tijburg PNM, Ryan J, Stern DM, Wollitzky B, Rimon S, Rimon A, Handley D, Nawroth P, Sixma JJ, de Groot PG: Activation of the coagulation mechanism on tumor necrosis factor-stimulated cultured endothelial cells and their extracellular matrix. J Biol Chem 266:12067, 1991
21. Lindhout T, Blezer R, Schoen P, Nordvang O, Reuteling-sperger C, Hemker HC: Activation of factor X and its regulation by tissue factor pathway inhibitor in small-diameter capillaries lined with human endothelial cells. Blood 79:2909, 1992
22. Bajaj SP, Rapaport SI, Brown SF: Isolation and characterization of human factor VlI. J Biol Chem 256:253, 1981
23. Miletich JP, Jackson CM, Majerus PW: Properties of the factor Xa binding site on human platelets. J Biol Chem 253:6908, 1978
24. Bock PE, Craig PA, Olson ST, Singh P: Isolation of human blood coagulation α-factor Xa by soybean trypsin inhibitor Sepharose chromatography and its active site titration. Arch Biochem Biophys 273:375, 1989
25. Wun T, Huang MD, Kretzmer KK, Palmier MO, Day KC, Bulock JW, Fok KF, Broze GJ Jr: Immunoaffinity purification and characterization of lipoprotein-associated coagulation inhibitors from Hep G2 hepatoma, Chang liver and SK hepatoma cells. J Biol Chem 265:16096, 1990
26. Sandset PM, Abilgaard U, Pettersen M: A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions. Thromb Res 47:389, 1987
27. Novotny FN, Girard TJ, Miletich JP, Broze GJ Jr: Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. J Biol Chem 264:18832, 1989
28. Broze GJ Jr, MacPhail L, Lange GW, Duffin KL: Heterogeneity of plasma tissue factor pathway inhibitor (TFPI). Blood 82:450a, 1993 (abstr, suppl 1)
29. Huang ZF, Wun TC, Broze GJ Jr: Kinetics of Xa inhibition by tissue factor pathway inhibitor. J Biol Chem 268:26950, 1993
30. Wesselschmidt R, Likert K, Girard TJ, Wun TC, Broze GJ Jr: Tissue factor pathway inhibitor: The carboxy terminus is required for optimal inhibition of factor Xa. Blood 79:2004, 1992
31. Nordvang O, Bjorn SE, Valentin S, Nielsen LS, Wildgoose P, Beck TC, Hedner U: The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity. Biochemistry 30:10371, 1991
32. Lindahl AK, Jakobsen PB, Sandset PM, Abilgaard U: Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patients. Blood Coagul Fibrinolysis 2:713, 1991
33. Kane WH, Majerus PW: Purification and characterization of human coagulation factor V. J Biol Chem 256:1002, 1981
34. Fujikawa K, Thompson AR, Legaz ME, Meyer RG, Davie EW: Isolation and characterization of bovine factor IX. Biochemistry 26:4938, 1973
35. Mertens K, Cupers R, van Wijngaarden A, Bertina RM: Binding of human coagulation factors IXa and X to phospholipid membranes. Biochem J 233:599, 1984
36. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of endothelial cells derived from umbilical veins. Identification by morphological and immunological criteria. J Clin Invest 52:2745, 1973
37. Zwaginga JJ, Sixma JJ, de Groot PG: Activation of endothelial cells with phorbol myristate acetate, tumor necrosis factor or endotoxin induces platelet thrombus formation on their matrix. Studies of a new in vitro model using low molecular weight heparin as anticoagulant. Arteriosclerosis 10:49, 1990
38. Sakariassen KS, Aarts PAMM, de Groot PG, Houdijk WPM, Sixma JJ: A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix and purified components. J Lab Clin Med 102:522, 1983
39. Uijttewaal WSJ: Development of a laser-doppler system for measuring particle distributions in narrow flow channels (doctorate thesis). State University of Utrecht, The Netherlands, 1993, chapter 4, p41
40. Giesen PLA, Willems GM, Hemker HC, Hermens WT: Membrane-mediated assembly of the prothrombinase complex. J Biol Chem 266:18720, 1991
41. Lindhout T, Willems G, Blezer R, Hemker HC: Kinetics of inhibition of human factor Xa by full length and truncated recombinant tissue factor pathway inhibitor. Biochem J 297:131, 1994
42. Broze GJ Jr, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP: The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits FXa: Insight in its possible mechanism of action. Blood 71:335, 1988
43. Sixma JJ, van de Berg A: The haemostatic plug in haemophilia: A morphological study of haemostatic plug formation in bleeding time skin wounds of patients with severe haemophilia A. Br J Haematol 58:741, 1984
44. Novotny WF, Girard TJ, Mileticg JP, Broze GJ Jr: Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood 72:2020, 1988
45. Erhardtsen E, Madsen MT, Ezban M, Hedner U, Diness V, Glazer S, Nordvang O: Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced hemophilia A. Thromb Haemost 69:556, 1993
46. Nesheim ME, Canfield WM, Kisiel W, Mann KG: Studies of the capacity of factor Xa to protect factor Va by activated protein C. J Biol Chem 257:1443, 1982
47. Solymoss S, Tucker MM, Tracy PB: Kinetics of inactivation of membrane-bound factor Va by activated protein C. Protein S modulates factor Xa protection. J Biol Chem 263:14884, 1988